(S)-Crizotinib (Standard)

Overview

(S)-Crizotinib (Standard) is the analytical standard of (S)-Crizotinib ( HY-100549 ). This product is intended for research and analytical applications. (S)-Crizotinib is a potent and selective MTH1 (mutT homologue) inhibitor with an IC50 of 330 nM. (S)-Crizotinib disrupts nucleotide pool homeostasis via MTH1 inhibition, induces an increase in DNA single strand breaks, activates DNA repair in human colon carcinoma cells, and effectively suppresses tumour growth in animal models.

Application

Products | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Others | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > DNA/RNA Synthesis | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Apoptosis

Product Information

• Catalog No.: HY-100549R
• CAS No.: 1374356-45-2
• Molecular Formula: C21H22Cl2FN5O
• Molecular Weight: 450.34
• Purity: 98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source